Report Categories
View AllRecent Articles
View All
Genprex GNPX EPS beats by 38 yet shares decline 284 as revenue questions linger
LATAW Galata quarterly earnings metrics not yet released no notable share price movement recorded as of today
ASML Holding ASML Wall Street Analysts Project 26 12Month Upside Amid Semiconductor Sector Resilience
Regeneron Pharmaceuticals REGN TD Cowen Ups Price Target Ahead of Fiscal Q1 Results Supported by FDA Gene Therapy Approval
Why TD SYNNEX SNX earnings beat or miss matters less than you think SNX TD SYNNEX Q1 2026 Earnings EPS Smashes Estimates by 41
REZI Resideo Technologies posts Q4 2025 EPS miss but rises 129 percent as investors overlook modest underperformance
Occidental Petroleum OXY Durable Competitive Moats Berkshire Backing Support Continued MarketBeating Performance
Is BioAtla BCAB stock reacting to key levels Q4 2025 Earnings Beat Estimates
VSH Vishay Intertechnology shares drop 3 as EPS misses by 50 despite revenue growth of 45
Equinix Inc EQIX Q1 2026 Earnings Top Expectations on AI Infrastructure Demand FullYear Guidance Lifted
External Links
OFS OFSSH Stock Is It Building Momentum OFS records 139 EPS miss falling short of consensus estimates
Intercontinental Exchange ICE NYSE Composite Index Reaches New Milestone as IPO Activity Intensifies
MORN Morningstar Q1 results exceed expectations with 17 EPS beat revenue up 75 yearoveryear
FISV Fiserv delivers positive 28 percent Q4 2025 EPS surprise shares gain 102 percent in todays session
Is Halozyme Therapeutics HALO stock cheap relative to earnings growth Q4 2025 Profit Disappoints
OAKU Oak Woods shares updates on its SPAC merger search while releasing its latest quarterly earnings
Power PSIX Stock Buy Side Rating Mini Selloff 20260427